Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01165_DB01623_nanopub.RA0jJ5n_bqbUhBHRL8YqKlCO4kzXjG9kfoztif6kthaWc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01165_DB01623 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01165_DB01623 label "DDI between Ofloxacin and Thiothixene - The strong CYP1A2 inhibitor, Ofloxacin, may decrease the metabolism and clearance of Thiothixene, a CYP1A2 substrate. Consider alternate therapy or monitor for changes in Thiothixene therapeutic and adverse effects if Ofloxacin is initiated, discontinued or dose changed. [drugbank_resource:DB01165_DB01623]" assertion.
- drugbank_resource:DB01165_DB01623 identifier "drugbank_resource:DB01165_DB01623" assertion.
- drugbank_resource:DB01165_DB01623 title "DDI between Ofloxacin and Thiothixene - The strong CYP1A2 inhibitor, Ofloxacin, may decrease the metabolism and clearance of Thiothixene, a CYP1A2 substrate. Consider alternate therapy or monitor for changes in Thiothixene therapeutic and adverse effects if Ofloxacin is initiated, discontinued or dose changed." assertion.
- drugbank:DB01165 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01165_DB01623 assertion.
- drugbank:DB01623 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01165_DB01623 assertion.